Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VIR
VIR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VIR News
Superstring Capital Acquires New Position in Vir Biotechnology
May 23 2026
Fool
Superstring Capital Acquires Shares in Vir Biotechnology
May 23 2026
NASDAQ.COM
SB Investment Advisers Reduces Stake in Vir Biotechnology
May 18 2026
Fool
Boxer Capital Increases Stake in Vir Biotechnology
May 17 2026
Fool
GT Biopharma Initiates Phase 1 Trial of GTB-5550 for Solid Tumors
May 14 2026
Newsfilter
Vicki Sato Sells 22,000 Shares of Vir Biotechnology Stock
May 09 2026
Fool
Vir Biotechnology Q1 2026 Earnings Call Insights Highlight Strategic Developments
May 07 2026
seekingalpha
Vir Biotechnology Q1 Earnings Miss Expectations with Significant Cash Position
May 06 2026
seekingalpha
Vir Biotechnology to Announce Q1 Earnings on May 6
May 05 2026
seekingalpha
Vir Biotechnology CEO Sells 72,559 Shares in Open-Market Transaction
Apr 12 2026
Fool
Vir Biotechnology CEO Sells Shares Amid Positive Trial Results
Apr 12 2026
NASDAQ.COM
Wall Street Analysts Adjust Ratings
Mar 04 2026
Benzinga
Significant Milestones in Biotech Sector This Week
Feb 27 2026
NASDAQ.COM
Vir Biotechnology Announces Pricing of Public Offering
Feb 26 2026
NASDAQ.COM
Marriott Vacations Reports Strong Q4, Shares Surge
Feb 26 2026
Benzinga
Vir Biotechnology Prices Public Offering at $8.50 per Share
Feb 26 2026
seekingalpha
Show More News
